Solvetta 2 mg Tablets.
PDF Leaflet Revision Date: 15 March 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of endometriosis.
Dosage (summary)
1 tablet daily, starting on day 1 of the menstrual cycle.
Special Populations
- Adolescents (12 years and older)
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding.
Key Drug Interactions
- CYP3A4 inducers (e.g., phenytoin, rifampicin)
- CYP3A4 inhibitors (e.g., azole antifungals)
Contraindications
- Hypersensitivity
- Venous thromboembolic disorder
- Cardiovascular diseases
- Severe hepatic disease
- Liver tumors
- Sex hormone-dependent malignancies
- Undiagnosed vaginal bleeding
Common side effects
- Nausea
- Headache
- Depressed mood
- Weight changes
- Breast discomfort
Counselling Points
- Take at the same time daily
- Use non-hormonal contraception if needed
- Report mood changes
- Consider calcium and Vitamin D intake
Serious warnings
- Increased risk of thromboembolism
- Changes in bone mineral density
- Monitor for depression
Important Disclaimer
The Solvetta 2 mg Tablets. professional information leaflet below is the property of Sandoz Sa 1 and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
